RB1 and retinoblastoma: This mechanism is highly prevalent and well-illustrated by the hyper-methylation of the promoters of RB1 in retinoblastoma [7], of the MLH1 promoter in colon cancer [8, 9], and of the BRCA1 promoter in breast cancer [10].